4 months Ionis Pharmaceuticals (NASDAQ:IONS) Rating Lowered to Sell at StockNews.com MarketBeat

StockNews.com lowered shares of Ionis Pharmaceuticals from a “hold” rating to a “sell” rating in a research note on Friday.